Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | -0.22% | -3.00% | -33.09% |
04-12 | Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director | CI |
04-02 | UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating | MT |
Business Summary
Number of employees: 480
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapies
100.0
%
| 106 | 100.0 % | 16 | 100.0 % | -85.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matt Kapusta
CEO | Chief Executive Officer | 51 | 31/12/14 |
Christian Klemt
DFI | Director of Finance/CFO | 51 | 31/12/14 |
Pierre Caloz
COO | Chief Operating Officer | 52 | 16/05/21 |
Richard Porter
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Jeannette Potts
CMP | Compliance Officer | 62 | - |
Walid Abi-Saab
CTO | Chief Tech/Sci/R&D Officer | 59 | 25/06/23 |
Robert Gut
BRD | Director/Board Member | 59 | 12/06/18 |
Maria E. Cantor
IRO | Public Communications Contact | 56 | 26/06/16 |
Erin Boyer
HRO | Human Resources Officer | - | 31/03/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Post
BRD | Director/Board Member | 72 | 16/06/20 |
Jack Kaye
BRD | Director/Board Member | 80 | 14/06/16 |
Director/Board Member | 61 | 13/09/17 | |
Matt Kapusta
CEO | Chief Executive Officer | 51 | 31/12/14 |
David Meek
CHM | Chairman | 59 | 12/06/18 |
Director/Board Member | 73 | 13/09/17 | |
Director/Board Member | 56 | 30/06/13 | |
Robert Gut
BRD | Director/Board Member | 59 | 12/06/18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 20/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,838,275 | 43,109,998 ( 90.12 %) | 0 | 90.12 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.09% | 220M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.41% | 22.15B | |
-17.37% | 21.02B | |
-8.26% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- QURE Stock
- Company uniQure N.V.